Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
T
066700
vs
K
KOSPI 200
Over the past 12 months, Theragen Etex Co Ltd has underperformed KOSPI 200, delivering a return of -26% compared to KOSPI 200's +35% growth.
Stocks Performance
066700 vs KOSPI 200
Performance Gap
066700 vs KOSPI 200
Create a free account · No card needed
Performance By Year
066700 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Theragen Etex Co Ltd
Glance View
Theragen Etex Co Ltd is a South Korean healthcare company focused on genetic testing and precision medicine. It develops and sells molecular diagnostic tests that look for disease markers in DNA and RNA, and it also works with hospitals, labs, and doctors that need test results to help diagnose disease and guide treatment choices. Its business sits in the middle of the healthcare chain, turning biological samples into medical information that clinicians can use. The company makes money mainly by selling diagnostic test kits, lab services, and related genetic analysis products. Its customers include hospitals, medical laboratories, research groups, and sometimes pharmaceutical companies that need companion diagnostics or genetic data for drug development. In simple terms, Theragen Etex earns revenue when its tests are used, its kits are purchased, or its analysis services are ordered. What makes the business different is that it depends on specialized science and regulated testing know-how rather than mass-market products. A company like this can build long-term relationships with healthcare providers because its value comes from accurate results, disease-specific testing, and the ability to support personalized medicine. That gives it a role as a technical service provider in a field where doctors and drug makers increasingly rely on genetic information.
Create a free account · No card needed